Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review

Br J Haematol. 2023 Jan;200(2):249-255. doi: 10.1111/bjh.18485. Epub 2022 Sep 30.

Abstract

Erythrocytosis is associated with increased red blood cell mass and can be either congenital or acquired. Congenital secondary causes are rare and include germline variants increasing haemoglobin (Hb)-oxygen affinity (e.g., Hb or bisphosphoglycerate mutase (BPGM) variants) or affecting oxygen-sensing pathway proteins. Here, we describe five adults from three kindreds with erythrocytosis associated with heterozygosity for BPGM variants, including one novel. Functional analyses showed partial BPGM deficiency, reduced 2,3-bisphosphoglycerate levels and/or increased Hb-oxygen affinity. We also review currently known BPGM variants. This study contributes to raising awareness of BPGM variants, and in particular that heterozygosity for BPGM deficiency may already manifest clinically.

Publication types

  • Review

MeSH terms

  • Adult
  • Anemia, Hemolytic*
  • Bisphosphoglycerate Mutase / genetics
  • Hemoglobins
  • Heterozygote
  • Humans
  • Metabolism, Inborn Errors*
  • Oxygen
  • Polycythemia* / congenital

Substances

  • Bisphosphoglycerate Mutase
  • Hemoglobins
  • Oxygen

Supplementary concepts

  • Polycythemia, primary familial and congenital